Evidence map›Paper›PMID 40567342›Full record

ArticleJournal of public health research2025

Building healthcare capacity for neurodegenerative disease management in Nigeria: Challenges and opportunities.

Elechi Kelechi Wisdom, Toluwalashe Soyemi, Shekoni Mayowa, Nwakaego Stephanie Ede, Elechi Ubalaeze Solomon, Chukwuagoziem Augustine Iloanusi, Chinonyelum Emmanuel Agbo, Obehi Suzan Idogen, Cletus Augustine Ikechukwu, Okechukwu Clinton Ifeanyi and 4 more

Abstract read
In one paragraph

Article in Journal of public health research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Elechi Kelechi WisdomIntegrated Biomedical Sciences, Graduate School of Biomedical Sciences, University of Texas Health Science Center, San Antonio, TX, USA.ORCID https://orcid.org/0000-0003-0691-4180
Toluwalashe SoyemiDepartment of Medicine and Surgery, Lagos State University College of Medicine, Ikeja, Nigeria.
Shekoni MayowaDepartment of Community Health and Primary Healthcare, Lagos State University College of Medicine, Ikeja, Nigeria.
Nwakaego Stephanie EdeDepartment of Physiotherapy, Faculty of Basic Medical Sciences, College of Medicine, University of Benin, Edo, Nigeria.
Elechi Ubalaeze SolomonDepartment of Radiography and Radiological Sciences, Faculty of Health Science and Technology, University of Nigeria Enugu Campus, Nigeria.
Chukwuagoziem Augustine IloanusiFaculty of Clinical Sciences, University of Uyo, Nigeria.
Chinonyelum Emmanuel AgboDepartment of Clinical Pharmacy and Pharmacy Management, Faculty of Pharmaceutical Sciences, University of Nigeria, Nsukka, Nigeria.
Obehi Suzan IdogenDepartment of Optometry, Faculty of Life Sciences, University of Benin, Edo, Nigeria.
Cletus Augustine IkechukwuDepartment of Medical Laboratory Science, Ebonyi State University, Abakaliki, Nigeria.
Okechukwu Clinton IfeanyiDepartment of Optometry, Faculty of Life Sciences, University of Benin, Edo, Nigeria.
Christiana Komeno AkpowowoDepartment of Medical Biochemistry, Faculty of Basic Medical Sciences, Delta State University, Abraka, Nigeria.
Farounbi Glory OyebolaDepartment of Medicine and Surgery, Lagos State University College of Medicine, Ikeja, Nigeria.
Chidinma NndoumeleDepartment of Anatomy, Nnamdi Azikiwwe University Awka, Anambra State, Nigeria.
Lawal Olabisi PromiseDepartment of Medical Laboratory Science, University of Benin, Edo State, Nigeria.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neurodegenerative diseases (NDs) such as Alzheimer's disease (AD) and Parkinson's disease (PD) are growing public health concerns worldwide, and their burden is particularly severe in low- and middle-income countries, including Nigeria. This perspective highlights the urgent need for tailored public health strategies to address the rising prevalence of these diseases, focusing on prevention, early detection, and management in the Nigerian context. With an aging population and limited healthcare infrastructure, Nigeria faces unique challenges in diagnosing and treating NDs. Cultural factors, such as stigma and misconceptions about cognitive decline, further complicate timely intervention. The paper explores the current public health strategies implemented to combat these diseases, including lifestyle modifications, national policy development, and public-private partnerships. It emphasizes the need for community-based programs, the integration of primary healthcare and neurology, and increased awareness to reduce the societal burden of NDs. Additionally, the manuscript discusses the essential role of training healthcare providers and the integration of traditional and modern medicine in enhancing care. It calls for a coordinated, culturally relevant approach to addressing the rising tide of neurodegenerative diseases in Nigeria, with recommendations for policy reform, healthcare system strengthening, and greater research investment.

Indexed as

brain healthearly detectionhealthcare policyneurodegenerative diseasesNigeriapublic health

Identifiers

PMID40567342
PMCPMC12188034

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.